Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ROZENCWEIG M")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 104

  • Page / 5
Export

Selection :

  • and

CHIMIOTHERAPIE DES TUMEURS NON SEMINOMATEUSES DU TESTICULEABELE R; ROZENCWEIG M.1980; NOUV. PRESSE MED.; ISSN 0301-1518; FRA; DA. 1980; VOL. 9; NO 45; PP. 3449-3454; ABS. ENG; BIBL. 52 REF.Article

DETERMINATION IN VITRO DE L'ACTIVITE ANTITUMORALE DE LA CHIMIOTHERAPIEPICCART M; ROZENCWEIG M.1983; REVUE MEDICALE DE BRUXELLES; ISSN 0035-3639; BEL; DA. 1983; VOL. 4; NO 3; PP. 147-149; ABS. ENG; BIBL. 7 REF.Article

CLINICAL IMPLICATIONS OF CISPLATIN PHARMACOLOGYMUGGIA FM; ROZENCWEIG M; PENTA J et al.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 74; PP. 132-138; BIBL. 19 REF.Article

THE EVALUATION OF CYTOTOXIC DRUGSVON HOFF DD; ROZENCWEIG M; MUGGIA FM et al.1979; CANCER TREATM. REV.; GBR; DA. 1979; VOL. 6; SUPPL.; PP. 1-8; H.T. 1; BIBL. 13 REF.Conference Paper

DAUNOMYCIN: AN ANTHRACYCLINE ANTIBIOTIC EFFECTIVE IN ACUTE LEUKEMIA.VON HOFF DD; ROZENCWEIG M; SLAVIK M et al.1978; ADV. PHARMACOL. CHEMOTHERAPY; USA; DA. 1978; VOL. 15; PP. 1-50; BIBL. 5 P.Article

LE TRAITEMENT DE LA MALADIE DE HODGKIN AUX DIFFERENTS STADES CLINIQUESKENIS Y; ABELE R; ROZENCWEIG M et al.1980; REV. MED. BRUXELLES; BEL; DA. 1980; VOL. 1; NO 5; PP. 299-305; ABS. ENG; BIBL. 30 REF.Article

INVESTIGATIONAL CHEMOTHERAPEUTIC AGENTS IN HEAD AND NECK CANCER.ROZENCWEIG M; VON HOFF DD; MUGGIA FM et al.1977; SEMINARS IN ONCOL.; U.S.A.; DA. 1977; VOL. 4; NO 4; PP. 425-429; BIBL. 1 P. 1/2Article

ANTIBACTERIAL ACTIVITY AND PHARMACOKINETICS OF BACAMPICILLIN AND AMPICILLINROZENCWEIG M; STAQUET M; KLASTERSKY J et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 19; NO 5 PART. 1; PP. 592-597; BIBL. 17 REF.Article

CYTEMBENA: AN ANTICANCER DRUG WITH AN UNIQUE STRUCTURE.VON HOFF DD; ROZENCWEIG M; MUGGIA FM et al.1977; BIOMEDICINE; FR.; DA. 1977; VOL. 26; NO 6; PP. 388-392; BIBL. 38 REF.Article

PHASE I CLINICAL TRIAL WITH A COMBINATION OF METHOTREXATE AND MITOMYCIN CBODY JJ; ROZENCWEIG M; KENIS Y et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 6; NO 2; PP. 197-198; BIBL. 5 REF.Article

ROLE DES NOUVEAUX MEDICAMENTS DANS LA CHIMIOTHERAPIE ANTICANCEREUSEROZENCWEIG M; ABELE R; BEDOGNI P et al.1980; REV. MED. BRUXELLES; BEL; DA. 1980; VOL. 1; NO 5; PP. 325-329; ABS. ENG; BIBL. 26 REF.Article

THE DELTA AND EPSILON ERRORS IN THE ASSESSMENT OF CANCER CLINICAL TRIALSSTAQUET MJ; ROZENCWEIG M; VON HOFF DD et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 1917-1921; BIBL. 19 REF.Article

EORTC RANDOMIZED TRIAL FOR THE ADJUVANT THERAPY OF T1 BLADDER CARCINOMA.SCHULMAN CC; ROZENCWEIG M; STAQUET M et al.1976; EUROP. UROL.; SWITZ.; DA. 1976; VOL. 2; NO 6; PP. 271-273; BIBL. 13 REF.Article

OVERVIEW OF EARLY AND INVESTIGATIONAL CHEMOTHERAPEUTIC AGENTS IN SOLID TUMORS.ROZENCWEIG M; SLAVIK M; MUGGIA FM et al.1976; MED. PEDIATR. ONCOL.; U.S.A.; DA. 1976; VOL. 2; NO 4; PP. 417-432; BIBL. 4 P. 1/2Article

CULTURE CLONOGENIQUE DE TUMEURS HUMAINES. EXPERIENCE ET PERSPECTIVES POUR LA CHIMIOTHERAPIE DU CANCERROZENCWEIG M; MAKAROFF O; PREVOST JM et al.1982; NOUV. PRESSE MED.; ISSN 0301-1518; FRA; DA. 1982; VOL. 11; NO 14; PP. 1071-1074; ABS. ENG; BIBL. 15 REF.Article

ABSORPTION OF M-AMSA AND ITS BILIARY METABOLITES FROM THE RAT SMALL INTESTINEGORMLEY PE; SHOEMAKER D; ROZENCWEIG M et al.1981; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1981; VOL. 17; NO 10; PP. 1143-1146; BIBL. 8 REF.Article

PERITONEOSCOPY AS A DIAGNOSTIC SUPPLEMENT TO LIVER FUNCTION TESTS AND LIVER SCAN IN PATIENTS WITH CARCINOMA.BLEIBERG H; ROZENCWEIG M; LONGEVAL E et al.1977; SURG. GYNECOL. OBSTETR.; U.S.A.; DA. 1977; VOL. 145; NO 6; PP. 821-825; BIBL. 6 REF.Article

New anticancer drugs: mitoxantrone and bisantrene. Symposium held at the institute Jules Bordet, Brussels, in October 1981 = Nouvelles drogues anticancéreuses: mitoxantrone et bisantrène. Symposium tenu à l'institut Jules Bordet Bruxelles, Octobre 1981ROZENCWEIG, M; VONHOFF, D. D.Monograph series of the European Organization for Research on Treatment of Cancer. 1983, Vol 12, issn 0146-0447, XV-194Conference Proceedings

LONG-TERM SURVIVORS WITH SMALL CELL CARCINOMA OF THE LUNGMATTHEWS MJ; ROZENCWEIG M; STAQUET MJ et al.1980; EUROP. J. CANCER; GBR; DA. 1980; VOL. 16; NO 4; PP. 527-531; BIBL. 9 REF.Article

INCREASED TRITIATED THYMIDINE-LABELING INDEX OF BONE MARROW MYELOBLASTS FOLLOWING BCG ADMINISTRATION IN MAN.ROZENCWEIG M; STRYCKMANS P; FICHEFET JP et al.1978; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1978; VOL. 4; NO 3; PP. 197-199; BIBL. 19 REF.Article

PHARMACOKINETICS OF ADRIAMYCIN AND ADRIAMYCIN - DNA COMPLEX IN L1210 MICE AND MEN.STAQUET M; ROZENCWEIG M; DUARTE KARIM M et al.1977; EUROP. J. CANCER; G.B.; DA. 1977; VOL. 13; NO 4-5; PP. 433-435; BIBL. 11 REF.Article

THROMBOPHLEBITIC POTENTIAL OF INTRAVENOUS CYTOTOXIC AGENTS.HENNEY JE; VON HOFF DD; ROZENCWEIG M et al.1977; DRUG INTELLIG. CLIN. PHARM.; U.S.A.; DA. 1977; VOL. 11; NO 5; PP. 266-267Article

VM 26 AND VP 16-213: A COMPARATIVE ANALYSIS.ROZENCWEIG M; VON HOFF DD; HENNEY JE et al.1977; CANCER; U.S.A.; DA. 1977; VOL. 40; NO 1; PP. 334-342; BIBL. 2 P. 1/2Article

Clinical evaluation of antitumor therapyMUGGIA, F. M; ROZENCWEIG, M.Developments in oncology. 1986, Vol 46, issn 0167-4927, XII-219 pSerial Issue

CLINICAL TRIALS WITH THE HEXITOL DERIVATIVES IN THE U.S.CHIUTEN DF; ROZENCWEIG M; VON HOFF DD et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 3; PP. 442-451; BIBL. 68 REF.Article

  • Page / 5